16.01.2006 12:35:00

Dr. Reddy's to Release Q3 FY06 results on January 24, 2006; Earnings Call Slated for January 24, 6:30 PM IST/8:00 AM EST

Dr. Reddy's Laboratories (NYSE:RDY) will announceresults for the quarter ended December 31, 2005 on Tuesday, January24th 2006, after the Board Meeting. The results will be available onthe Company's website www.drreddys.com .
Summary of Events

Event Date and Time (IST) Medium

Release of financial January 24, after the Email, Media,
results Board Meeting Company website,
Business Wire

Earnings Call January 24, 6.30 PM Hosted by the
IST / 8.00 AM EST Company
(Details below)

Webcast of Earnings January 24, 6.30 PM URL available on
Call IST / 8.00 AM EST Company's
through April 23, 2006 website,
www.drreddys.com

Transcripts of the Within 10 working days URL available on
Earnings call of the Call Company's
website,
www.drreddys.com

Earnings Call

Following the release, the management of the Company will host anearnings call to discuss the Company's financial performance.
Date Timing Dial-in number
----------------- ---------------------- ---------------------------
January 24, 2006 India - 6.30 PM Participants from India
US EST - 8.00 AM 022.2781.2277

Stand by - 022 5591 7977

Participants from the US
1 877 209 0463
Conference ID: 4054397#

Participants outside India
& US (Singtel bridge)
65 666 87512
Conference Code: 409283#
----------------- ---------------------- ---------------------------

No password/pin number is necessary to dial in to any of the othercalls. As participation in the call is limited, early registration isencouraged. The operator will provide instructions on asking questionsbefore and during the call.

Audio Webcast

The audio webcast of the earnings call will be available to allinterested parties at www.drreddys.com. Please visit the web site atleast fifteen minutes ahead of the scheduled start time to registerand to download and install any necessary audio software. Participantsin the webcast can listen to the proceedings, but will not be able toask questions. The replay will be available 2 hours after the earningscall, through April 23, 2006.

Transcript

The transcript of the earnings call will also be available on theCompany's website within 10 workings days of the call.

About Dr Reddy's

Established in 1984, Dr. Reddy's Laboratories (NYSE:RDY) is anemerging global pharmaceutical company with proven basic researchcapabilities. The company develops, manufactures and markets a widerange of pharmaceutical products in India and overseas. Dr. Reddy'sproduces finished dosage forms, active pharmaceutical ingredients,diagnostic kits, critical care and biotechnology products. The basicresearch program of Dr. Reddy's focuses on cancer, diabetes, bacterialinfections and pain management. Website: http://www.drreddys.com

Safe Harbor

This press release includes forward-looking statements, as definedin the U.S. Private Securities Litigation Reform Act of 1995. We havebased these forward-looking statements on our current expectations andprojections about future events. Such statements involve known andunknown risks, uncertainties and other factors that may cause actualresults to differ materially. Such factors include, but are notlimited to, changes in local and global economic conditions, ourability to successfully implement our strategy, the market acceptanceof and demand for our products, our growth and expansion,technological change and our exposure to market risks. By theirnature, these expectations and projections are only estimates andcould be materially different from actual results in the future.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

DBIX India Net 1 288,29 -0,96%